New predatory interaction of Trichonephila clavipes (Araneae: Nephilidae) on Fidicinini (Hemiptera: Cicadidae) in a forest fragment of the Neotropical region

Posted by
  New predatory interaction of Trichonephila clavipes (Araneae: Nephilidae) on Fidicinini (Hemiptera: Cicadidae) in a forest fragment of the Neotropical region Abstract Trichonephila clavipes (Araneae: Nephilidae) is an orb web-building spider whose diet is primarily based on flying insects. This note aims to report the first predatory interaction of T. clavipes on a cicada of the genus Fidicina (Hemiptera: Cicadidae) in a fragment of the Atlantic Forest in Brazil. The predation event was observed (ad libitum) in the Benjamin Maranhão Botanical Garden situated in the Mata do Buraquinho Wildlife Refuge, northeastern Brazil. A specimen of Fidicina sp. was found freshly dead and trapped in the web of T. clavipes. The nephilid was observed moving slowly between the ventral and dorsal regions of the Fidicina sp. without weaving a web around the cicadid. Then, T. clavipes was observed perched on the left side of the Fidicina sp., with its pedipalps and chelicerae manipulating the thorax ...

The Synthetic Peptide LyeTx I mn∆K, Derived from Lycosa erythrognatha Spider Toxin, Is Active against Methicillin-Resistant Staphylococcus aureus (MRSA) In Vitro and In Vivo

Posted by

 


The Synthetic Peptide LyeTx I mn∆K, Derived from Lycosa erythrognatha Spider Toxin, Is Active against Methicillin-Resistant Staphylococcus aureus (MRSA) In Vitro and In Vivo

Abstract

The urgent global health challenge posed by methicillin-resistant Staphylococcus aureus (MRSA) infections demands effective solutions. Antimicrobial peptides (AMPs) represent promising tools of research of new antibacterial agents and LyeTx I mn∆K, a short synthetic peptide based on the Lycosa erythrognatha spider venom, is a good representative. This study focused on analyzing the antimicrobial activities of LyeTx I mn∆K, including minimum inhibitory and bactericidal concentrations, synergy and resensitization assays, lysis activity, the effect on biofilm, and the bacterial death curve in MRSA. Additionally, its characterization was conducted through isothermal titration calorimetry, dynamic light scattering, calcein release, and finally, efficacy in a mice wound model. The peptide demonstrates remarkable efficacy against planktonic cells (MIC 8–16 µM) and biofilms (>30% of inhibition) of MRSA, and outperforms vancomycin in terms of rapid bactericidal action and anti-biofilm effects. The mechanism involves significant membrane damage. Interactions with bacterial model membranes, including those with lysylphosphatidylglycerol (LysylPOPG) modifications, highlight the versatility and selectivity of this compound. Also, the peptide has the ability to sensitize resistant bacteria to conventional antibiotics, showing potential for combinatory therapy. Furthermore, using an in vivo model, this study showed that a formulated gel containing the peptide proved superior to vancomycin in treating MRSA-induced wounds in mice. Together, the results highlight LyeTx I mnΔK as a promising prototype for the development of effective therapeutic strategies against superficial MRSA infections.